Milena Jadrijevic-Mladar Takac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Milena Jadrijevic-Mladar Takac has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Danijela Bakarić
Division of Organic Chemistry and Biochemistry Ruđer Bošković Institute Bijenička 54 10000 Zagreb Croatia
1 shared publication- Dražen Vikić-Topić
NMR Centre, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia
1 shared publication - Katarina Mišković Špoljarić
Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Josipa Huttlera 4, 31000 Osijek, Croatia
1 shared publication - Marijana Zovko Končić
Department of Pharmacognosy, University of Zagreb Faculty of Pharmacy and Biochemistry, A. Kovačića 1, 10000 Zagreb, Croatia
1 shared publication - Mirela Baus Lončar
Division of Molecular Medicine, Ruđer Bošković Institute, Bijenička 54, 10 000 Zagreb, Croatia
1 shared publication - Monika Barbarić
Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10 000 Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 15 November 2021
- Published by Acta Pharmaceutica Hungarica in Acta Pharmaceutica Hungarica
- Vol. 91 (3-4) , 240-242
Estimating the Toxic Potential of Entactogens – In silico Study
- 15 November 2021
- Published by Acta Pharmaceutica Hungarica in Acta Pharmaceutica Hungarica
- Vol. 91 (3-4) , 240-242
Open AccessEstimating the Toxic Potential of Entactogens – In silico Study
- Open Access
- 14 November 2017
- Published by MDPI AG in Preprints.org
Spectroscopic Evidence, Evaluation of Biological Activity and Prediction of the Safety Profile of Fatty Hydroxamic Acids Derived from Olive Oil Triacylglycerides
A fatty hydroxamic acid (FHA) mixture synthesized from olive oil triacylglycerides by hydroxylaminolysis and composed predominantly of oleyl and linoleyl hydroxamic acid (OHA and LHA, respectively) was characterized by means of IR, Raman, MS and 1D and 2D 1H- and 13C-NMR spectroscopy. The ratio of OHA and LHA (4:1) was confirmed by MALDI TOF/TOF mass spectrometry. The radical scavenging and the Fe2+-chelating activity, as well as antioxidant activity in β-carotene-linoleic acid and the Fe3+-reducing power assays of the FHAs yielded positive results. The results of FHA cell toxicity on normal fibroblast (BJ) and a tumour cell line (HeLa) revealed that the normal cell line was sensitive to FHAs within the entire range of applied concentrations (5 × 10−4 mg/mL to 5 × 10−1 mg/mL), while the HeLa tumour cell line was sensitive only at the highest FHA concentration (5 × 10−1 mg/mL). In silico target prediction indicated cannabinoid receptors 1 and 2, the fatty-acid amide hydrolase 1 and hystone deacetylases as the most probable targets of OHA and LHA. According to ADMET predictor analysis, the safety profiles of OHA and LHA are comparable to that of SAHA (vorinostat) the histone deacetylase inhibitor in use as an antineoplastic and immunomodulating agent.
- 14 November 2017
- Published by MDPI AG in Preprints.org
Open AccessSpectroscopic Evidence, Evaluation of Biological Activity and Prediction of the Safety Profile of Fatty Hydroxamic Acids Derived from Olive Oil Triacylglycerides
A fatty hydroxamic acid (FHA) mixture synthesized from olive oil triacylglycerides by hydroxylaminolysis and composed predominantly of oleyl and linoleyl hydroxamic acid (OHA and LHA, respectively) was characterized by means of IR, Raman, MS and 1D and 2D 1H- and 13C-NMR spectroscopy. The ratio of OHA and LHA (4:1) was confirmed by MALDI TOF/TOF mass spectrometry. The radical scavenging and the Fe2+-chelating activity, as well as antioxidant activity in β-carotene-linoleic acid and the Fe3+-reducing power assays of the FHAs yielded positive results. The results of FHA cell toxicity on normal fibroblast (BJ) and a tumour cell line (HeLa) revealed that the normal cell line was sensitive to FHAs within the entire range of applied concentrations (5 × 10−4 mg/mL to 5 × 10−1 mg/mL), while the HeLa tumour cell line was sensitive only at the highest FHA concentration (5 × 10−1 mg/mL). In silico target prediction indicated cannabinoid receptors 1 and 2, the fatty-acid amide hydrolase 1 and hystone deacetylases as the most probable targets of OHA and LHA. According to ADMET predictor analysis, the safety profiles of OHA and LHA are comparable to that of SAHA (vorinostat) the histone deacetylase inhibitor in use as an antineoplastic and immunomodulating agent.